Technetium-99m-ethylenedicysteine in the diagnosis and follow-up of renovascular hypertension

Investigative Radiology

Volumn 31, Issue 6, 1996, Pages 378-381

  Uǧur, Ömer ^a   Caner, Biray ^a   Çekirge, Saruhan ^a   Balkanci, Ferhun ^a   Ergün, Eser Lay ^a   Kostakoǧlu, Lale ^a   Aras, Tülin ^a   Bekdik, Coşkun ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

captopril renal scintigraphy; percutaneous transluminal renal angioplasty; renal artery stenosis; Renovascular hypertension; technetium 99m ethylenedicysteine

Indexed keywords

CAPTOPRIL; FUROSEMIDE; N,N' ETHYLENEDICYSTEINE TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION;

EID: 0029945870     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199606000-00011     Document Type: Article

References (6)

1. Prigent A. The diagnosis of renovascular hypertension: The role of captopril renal scintigraphy and related issues. Eur J Nucl Med 1993;20:625-644.
2. Verbruggen AM, Nosco DL, Nerom VCG, Bormans GM, Adriaens PJ, De Roo MJ. Technetium-99m-L,L-ethylenedicysteine: A renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med 1992;33:551-557.
3. Nally JV, Chen C, Fine EJ, et al. Diagnosis criteria of renovascular hypertension with captopril renography: A consensus statement. Am J Hypertens 1991;4:S749-S752.
4. Sfakianakis GN, Vonorta K, Zilleruelo G, Jaffe D, Georgiou M. Scintigraphy in acquired renal disorders. In: Freeman LM, ed. Nuclear Medicine Annual. New York, NY: Raven Press; 1992: 157-224.
5. Sfakianakis GN, Bourgoigne JJ, Jaffe D, Kryiakides G, Perez-Stable E, Duncan RC. Single dose-captopril scintigraphy in the diagnosis of renovascular hypertension. J Nucl Med 1987;28: 1383-1392.
6. Kabasakal L, Turoǧlu HT, Önsel Ç, et al. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3, and iodine-131-OIH in renal disorders. J Nucl Med 1995;36:224-228.